Skip to main content
Boryung Corporation logo

Boryung Corporation — Investor Relations & Filings

Ticker · 003850 ISIN · KR7003850005 KO Manufacturing
Open in API
Filings indexed 354 across all filing types
Latest filing 2024-03-26 Board/Management Inform…
Country KR South Korea
Listing KO 003850

About Boryung Corporation

https://pharm.boryung.co.kr/eng/index.do

Boryung Corporation is a fully integrated healthcare company founded in 1957. Its core business encompasses the research, development, manufacturing, and global commercialization of pharmaceutical products, with a significant presence in the cardiovascular therapeutic area. The company is distinguished by its pioneering 'Care in Space' (CIS) initiative, which focuses on developing healthcare solutions for humans in extreme environments and leveraging space for new research opportunities. In addition to its pharmaceutical operations, Boryung functions as a healthcare investment company, fostering innovation across the health sector. The company's diverse portfolio includes prescription drugs, over-the-counter products, and a pipeline aimed at addressing future medical needs.

Recent filings

Filing Released Lang Actions
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment of an outside director (사외이사). This type of disclosure specifically concerns changes in the composition of the board of directors, which falls under the 'Board/Management Information' category.
2024-03-26 Korean
연결재무제표기준영업실적등에대한전망(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Fair Disclosure' (공정공시) filing from Boryung, which provides a forward-looking guidance (forecast) for the company's 2024 financial performance (revenue and operating profit) and compares the 2023 forecast against actual results. This type of regulatory filing, which provides management's outlook and financial projections, is best classified as a Management Report (MDA) as it explains business trends and outlook, or alternatively a Regulatory Filing (RNS). Given the specific nature of financial guidance and performance analysis, MDA is the most accurate fit. FY 2024
2024-03-19 Korean
사업보고서 (2023.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for Boryung Pharmaceutical (주식회사 보령) for the fiscal year ending December 31, 2023. It includes the independent auditor's report from Samjong KPMG, the financial statements (Statement of Financial Position, Comprehensive Income Statement, Statement of Changes in Equity, Statement of Cash Flows), and accompanying notes. It is a comprehensive financial audit document, not an earnings release or a summary, fitting the 'Audit Report' category. FY 2023
2024-03-12 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Boryung Corporation. It contains the meeting agenda, details on voting procedures (including electronic voting), and information regarding the board of directors and financial statements to be approved. This document is a formal notice sent to shareholders to convene the meeting, which falls under the category of Proxy Solicitation & Information Statement (PSI) as it provides the necessary information for shareholders to exercise their voting rights.
2024-03-11 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy) for Boryung Corporation. It contains detailed information regarding the upcoming Annual General Meeting (AGM), including the purpose of the meeting, voting procedures (electronic/proxy), and the agenda items (approval of financial statements, appointment of directors, etc.). This document is a standard proxy solicitation statement provided to shareholders to request their votes for the meeting.
2024-03-11 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by Boryung. It contains the auditor's opinion (unqualified/appropriate), financial highlights (assets, liabilities, equity, revenue, profit), and details regarding the accounting firm (KPMG Samjong). While it provides financial data, it is a standalone regulatory filing specifically for the submission of the audit report, which falls under the 'Audit Report / Information' category. FY 2023
2024-03-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.